4588.T
Oncolys BioPharma Inc.
グロース · 医薬品 · 医薬品 · JP
JPY 4,070.00
−0.49%Sep 1, 2026, 06:40 UTC
On September 1, 2026, four stocks hit limit-up and four hit limit-down at the close on the Tokyo Stock Exchange, including Brain's Technology, DeltaFly Pharma, Asterisk, and others.
Source:Aug 27, 2026, 22:30 UTC
Oncolys BioPharma announced that results of a Phase 2a clinical trial of LINE-1 inhibitor senzavudine for progressive supranuclear palsy were published in the overseas medical journal 'Movement Disorders'.
Aug 12, 2026, 05:57 UTC
Oncolys BioPharma announced that its cancer virus drug Telomelysin for esophageal cancer has been listed for insurance coverage and will be sold starting August 21, 2026.